Prise en charge nutritionnelle d’une ascite chyleuse

Chylous ascitis is a rare cause of ascitis. Most of the time, it results of retroperitoneal lymph node or duct dissection during abdominal or urological surgery; it is rarely due to lymphatic obstruction (neoplasia). Nutritional damage is major and severely impairs prognosis. Malnutrition is due to the necessity to avoid fatty acid in meal to reduce chylous leakage. Diagnosis is based on patient's clinical history and cytologic and biochemical ascitis analyses. Treatment combines the correction of nutritional status and therapy of the causative disease. Oral diet or enteral nutrition with low content of long chain triglyceride, thus enriched in medium chain triglyceride, is the major therapeutic option of chylous ascitis.     

Les bouchées enrichies adaptées,un outil à la portée des établissements sanitaires et médico-sociaux ainsi que des aidants familiaux : retour d’expérience

IntroductionFor many years, nutrition of the elderly is of a special attention. The food policies wants to value the regional initiatives that can be slowed down, and new techniques of adapted food are in development. Following a tracking of malnutrition in an establishment for dependent elderly, a program of nutritional improvement was set up. It was decided to transform the dishes of the daily menu into small enriched, mixed, prehensile mouthfuls, with for objective to use the remaining capacities of the patients, to adapt the care to their rhythm, to answer their expectations and their nutritional needs.MethodThe agents of texture of the mouthfuls were adapted. Their enrichment and their presentation were specified, as well as the modalities of distribution, in order to allow an easy access as well by the patients, the nursing and the families. Cooled cupboards were used.ResultsThe residents found again the pleasure to eat by themselves, their self-respect and consequently covered better their needs. A decrease of the malnutrition prevalence was observed. Times of exchange with other establishments and a formation were set up to share this tool. Levers were identified to develop this concept under good conditions.ConclusionThe adapted enriched mouthfuls tool seems to be useful. Its application is inseparable of a voluntary multidisciplinary approach, anchored in the knowledge of the accompanied person and in the analysis of her global situation. This tool is adaptable not only in any structure welcoming dependent, old people or not, but also at home.     

胰腺癌病人肠道通透性改变及其与血清蛋白关系的临床研究

目的:观察胰腺癌病人肠道通透性和营养状况的改变,初步探讨它们之间的关系. 方法:选取胰腺癌首次入院确诊的病人及健康志愿者各15例,作为试验组和对照组.分别测定尿乳果糖/甘露醇(L/M)比值、血清肿瘤坏死因子(TNF-α)、清蛋白(ALB)、转铁蛋白(TF)和前清蛋白(PA),并对试验组的肠道通透性与血清TNF-α水平、血清蛋白之间的相关性进行分析. 结果:试验组尿L/M比值显著高于对照组(0.331±0.343 vs 0.129± 0.136,P＜ 0.05).试验组血清TNF-α显著高于对照组,(4.98±6.46)ng/L vs (1.25±2.35)ng/L,P ＜0.05.试验组ALB、TF、PA浓度均较对照组显著降低(P ＜0.05).试验组尿L/M比值与血清TNF-α水平呈极显著正相关(P＜ 0.01)而与ALB、TF、PA均呈极显著的负相关(P＜0.01). 结论:胰腺癌病人肠道通透性增加与血清TNF-α水平升高呈显著正相关,与血清蛋白下降呈显著负相关.     

补肾排毒合剂治疗慢性肾衰竭营养不良60例临床观察

目的:观察补肾排毒合剂治疗慢性肾衰竭营养不良的疗效.方法:90例慢性肾衰竭营养不良患者随机分为治疗组60例和对照组30例,并设健康对照组30例.治疗组和对照组在综合治疗的基础上,治疗组加用补肾排毒合剂,对照组加用爱西特和百令胶囊.比较两组肾功能、营养状态和血浆瘦素、神经肽Y的变化.结果:治疗组治疗后BUN、Scr明显降低,与治疗前及对照组相比均有统计学差异(P<0.05).治疗组营养状态好转,与治疗前及对照组相比均有统计学差异(P<0.05).两组慢性肾衰竭营养不良患者治疗前Leptin、NPY水平均高于健康组(P<0.05),治疗后治疗组Leptin、NPY较治疗前下降,有统计学意义(P<0.05),但与对照组相比无统计学差异(P＞0.05).结论:补肾排毒合剂治疗慢性肾衰竭营养不良疗效明显,可降低BUN、Scr,改善营养不良状态.     

普外科住院患者营养状况评价

目的　调查本院 2 0 0 2～ 2 0 0 3年间普外科住院患者的营养状况。方法　采用多项营养评价指标测定 4 0 12例非急诊住院患者营养状况 ,分析年龄、疾病等因素与营养状况之间关系。结果　各项指标进行营养评价得出本院普外科非急诊患者营养不良的发生率分别是 :BMI 2 1 3% ,TSF5 0 6 % ,MAC 2 0 5 % ,AMC 2 1 2 % ,SGA 38 0 % ,MNA 2 0 8% ,ALB 2 4 2 % ,PA 35 4 % ,TLC 5 5 8%。 >6 0岁组老年患者、消化道疾病患者及恶性肿瘤患者营养不良发生率分别高于≤ 6 0岁患者、消化道外疾病患者及良性疾病患者 ,差异有显著性 (P <0 0 5 )。结论　本院普外科住院患者的营养不良发生率为 2 0 5 %～ 5 5 8% ,不同的营养评价指标得出的营养不良发生率不同。